The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): Beneficial or detrimental to endothelial barrier?

Natalia Bogatcheva, Marina A. Zemskova, Christophe Poirier, Tamara Mirzapoiazova, Irina Kolosova, Anne R. Bresnick, Alexander D. Verin

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Sepsis-induced vascular leakage is a major underlying cause of the respiratory dysfunction seen in severe sepsis. Here, we studied the role of MLC phosphorylation in LPS-induced endothelial hyperpermeability and assessed how the changes in phospho-MLC distribution affect LPS-induced barrier dysfunction. We demonstrated that the changes in human lung microvascular endothelial permeability are preceded by the increase in intracellular calcium level, and increase in MYPT and MLC phosphorylation. Using the siRNA approach, we showed that both LPS-induced barrier dysfunction and MLC phosphorylation are attenuated by the depletion of the smooth muscle isoform of MLC kinase (MLCK) and Rho kinase 2 (ROCK2). Surprisingly, pharmacological inhibition of both ROCK1 and 2 with Y-27632 exacerbated LPS-induced drop in transendothelial resistance, although significantly decreasing MLC phosphorylation level. We next studied the involvement of protein kinase A (PKA)-dependent pathways in LPS-induced barrier dysfunction. We showed that LPS decreased the level of PKA-dependent phosphorylation in endothelial cells; and the pretreatment with forskolin or PKA activator bnz-cAMP counteracted this effect. Forskolin and bnz-cAMP also attenuated LPS-induced increase in MLC phosphorylation level. As we have shown earlier (Bogatcheva et al., 2009), forskolin and bnz-cAMP provide protection from LPS-induced barrier dysfunction. We compared the effects of bnz-cAMP and Y-27632 on phospho-MLC distribution and observed that while bnz-cAMP increased the association of the phospho-MLC signal with the cortical structures, Y-27632 decreased this association. These data indicate that an overall decrease in MLC phosphorylation could be either beneficial or detrimental to endothelial barrier, depending on the intracellular locale of major phospho-MLC changes.

Original languageEnglish (US)
Pages (from-to)3132-3146
Number of pages15
JournalJournal of Cellular Physiology
Volume226
Issue number12
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Myosin Light Chains
Phosphorylation
Lipopolysaccharides
Colforsin
Cyclic AMP-Dependent Protein Kinases
Sepsis
Association reactions
Smooth Muscle Myosins
Myosin-Light-Chain Kinase
rho-Associated Kinases
Endothelial cells
Capillary Permeability
Small Interfering RNA
Blood Vessels
Muscle
Protein Isoforms
Endothelial Cells
Pharmacology
Calcium
Lung

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS) : Beneficial or detrimental to endothelial barrier? / Bogatcheva, Natalia; Zemskova, Marina A.; Poirier, Christophe; Mirzapoiazova, Tamara; Kolosova, Irina; Bresnick, Anne R.; Verin, Alexander D.

In: Journal of Cellular Physiology, Vol. 226, No. 12, 12.2011, p. 3132-3146.

Research output: Contribution to journalArticle

Bogatcheva, Natalia ; Zemskova, Marina A. ; Poirier, Christophe ; Mirzapoiazova, Tamara ; Kolosova, Irina ; Bresnick, Anne R. ; Verin, Alexander D. / The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS) : Beneficial or detrimental to endothelial barrier?. In: Journal of Cellular Physiology. 2011 ; Vol. 226, No. 12. pp. 3132-3146.
@article{3746bda6fcfe4b52abfe8c902a6ba218,
title = "The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): Beneficial or detrimental to endothelial barrier?",
abstract = "Sepsis-induced vascular leakage is a major underlying cause of the respiratory dysfunction seen in severe sepsis. Here, we studied the role of MLC phosphorylation in LPS-induced endothelial hyperpermeability and assessed how the changes in phospho-MLC distribution affect LPS-induced barrier dysfunction. We demonstrated that the changes in human lung microvascular endothelial permeability are preceded by the increase in intracellular calcium level, and increase in MYPT and MLC phosphorylation. Using the siRNA approach, we showed that both LPS-induced barrier dysfunction and MLC phosphorylation are attenuated by the depletion of the smooth muscle isoform of MLC kinase (MLCK) and Rho kinase 2 (ROCK2). Surprisingly, pharmacological inhibition of both ROCK1 and 2 with Y-27632 exacerbated LPS-induced drop in transendothelial resistance, although significantly decreasing MLC phosphorylation level. We next studied the involvement of protein kinase A (PKA)-dependent pathways in LPS-induced barrier dysfunction. We showed that LPS decreased the level of PKA-dependent phosphorylation in endothelial cells; and the pretreatment with forskolin or PKA activator bnz-cAMP counteracted this effect. Forskolin and bnz-cAMP also attenuated LPS-induced increase in MLC phosphorylation level. As we have shown earlier (Bogatcheva et al., 2009), forskolin and bnz-cAMP provide protection from LPS-induced barrier dysfunction. We compared the effects of bnz-cAMP and Y-27632 on phospho-MLC distribution and observed that while bnz-cAMP increased the association of the phospho-MLC signal with the cortical structures, Y-27632 decreased this association. These data indicate that an overall decrease in MLC phosphorylation could be either beneficial or detrimental to endothelial barrier, depending on the intracellular locale of major phospho-MLC changes.",
author = "Natalia Bogatcheva and Zemskova, {Marina A.} and Christophe Poirier and Tamara Mirzapoiazova and Irina Kolosova and Bresnick, {Anne R.} and Verin, {Alexander D.}",
year = "2011",
month = "12",
doi = "10.1002/jcp.22669",
language = "English (US)",
volume = "226",
pages = "3132--3146",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS)

T2 - Beneficial or detrimental to endothelial barrier?

AU - Bogatcheva, Natalia

AU - Zemskova, Marina A.

AU - Poirier, Christophe

AU - Mirzapoiazova, Tamara

AU - Kolosova, Irina

AU - Bresnick, Anne R.

AU - Verin, Alexander D.

PY - 2011/12

Y1 - 2011/12

N2 - Sepsis-induced vascular leakage is a major underlying cause of the respiratory dysfunction seen in severe sepsis. Here, we studied the role of MLC phosphorylation in LPS-induced endothelial hyperpermeability and assessed how the changes in phospho-MLC distribution affect LPS-induced barrier dysfunction. We demonstrated that the changes in human lung microvascular endothelial permeability are preceded by the increase in intracellular calcium level, and increase in MYPT and MLC phosphorylation. Using the siRNA approach, we showed that both LPS-induced barrier dysfunction and MLC phosphorylation are attenuated by the depletion of the smooth muscle isoform of MLC kinase (MLCK) and Rho kinase 2 (ROCK2). Surprisingly, pharmacological inhibition of both ROCK1 and 2 with Y-27632 exacerbated LPS-induced drop in transendothelial resistance, although significantly decreasing MLC phosphorylation level. We next studied the involvement of protein kinase A (PKA)-dependent pathways in LPS-induced barrier dysfunction. We showed that LPS decreased the level of PKA-dependent phosphorylation in endothelial cells; and the pretreatment with forskolin or PKA activator bnz-cAMP counteracted this effect. Forskolin and bnz-cAMP also attenuated LPS-induced increase in MLC phosphorylation level. As we have shown earlier (Bogatcheva et al., 2009), forskolin and bnz-cAMP provide protection from LPS-induced barrier dysfunction. We compared the effects of bnz-cAMP and Y-27632 on phospho-MLC distribution and observed that while bnz-cAMP increased the association of the phospho-MLC signal with the cortical structures, Y-27632 decreased this association. These data indicate that an overall decrease in MLC phosphorylation could be either beneficial or detrimental to endothelial barrier, depending on the intracellular locale of major phospho-MLC changes.

AB - Sepsis-induced vascular leakage is a major underlying cause of the respiratory dysfunction seen in severe sepsis. Here, we studied the role of MLC phosphorylation in LPS-induced endothelial hyperpermeability and assessed how the changes in phospho-MLC distribution affect LPS-induced barrier dysfunction. We demonstrated that the changes in human lung microvascular endothelial permeability are preceded by the increase in intracellular calcium level, and increase in MYPT and MLC phosphorylation. Using the siRNA approach, we showed that both LPS-induced barrier dysfunction and MLC phosphorylation are attenuated by the depletion of the smooth muscle isoform of MLC kinase (MLCK) and Rho kinase 2 (ROCK2). Surprisingly, pharmacological inhibition of both ROCK1 and 2 with Y-27632 exacerbated LPS-induced drop in transendothelial resistance, although significantly decreasing MLC phosphorylation level. We next studied the involvement of protein kinase A (PKA)-dependent pathways in LPS-induced barrier dysfunction. We showed that LPS decreased the level of PKA-dependent phosphorylation in endothelial cells; and the pretreatment with forskolin or PKA activator bnz-cAMP counteracted this effect. Forskolin and bnz-cAMP also attenuated LPS-induced increase in MLC phosphorylation level. As we have shown earlier (Bogatcheva et al., 2009), forskolin and bnz-cAMP provide protection from LPS-induced barrier dysfunction. We compared the effects of bnz-cAMP and Y-27632 on phospho-MLC distribution and observed that while bnz-cAMP increased the association of the phospho-MLC signal with the cortical structures, Y-27632 decreased this association. These data indicate that an overall decrease in MLC phosphorylation could be either beneficial or detrimental to endothelial barrier, depending on the intracellular locale of major phospho-MLC changes.

UR - http://www.scopus.com/inward/record.url?scp=80053166480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053166480&partnerID=8YFLogxK

U2 - 10.1002/jcp.22669

DO - 10.1002/jcp.22669

M3 - Article

C2 - 21302311

AN - SCOPUS:80053166480

VL - 226

SP - 3132

EP - 3146

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 12

ER -